Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,074	1,956	1,127	1,056	2,270	1,307
Market Cap Growth	44.45%	73.58%	6.69%	-53.48%	73.60%	-19.90%
Enterprise Value	2,892	1,751	960	1,049	2,276	1,033
Last Close Price	153.00	104.00	64.50	62.76	93.89	52.59
PE Ratio	74.23	-	23.88	-	45.18	-
PS Ratio	14.35	12.11	9.48	5.75	10.69	9.78
PB Ratio	3.80	2.44	1.78	1.89	3.14	2.25
P/TBV Ratio	5.86	4.42	4.18	8.11	7.85	-
P/FCF Ratio	117.24	21.26	27.04	8.99	36.86	31.90
P/OCF Ratio	112.99	20.86	25.12	8.19	32.76	29.30
EV/Sales Ratio	13.56	10.84	8.08	5.71	10.72	7.73
EV/EBITDA Ratio	59.55	31.11	22.90	27.11	22.09	18.31
EV/EBIT Ratio	156.24	78.73	108.04	369.11	39.07	30.77
EV/FCF Ratio	110.32	19.03	23.04	8.93	36.96	25.22
Debt / Equity Ratio	0.48	0.01	0.01	0.15	0.40	0.64
Debt / EBITDA Ratio	7.02	0.12	0.13	2.09	2.74	6.42
Debt / FCF Ratio	14.66	0.08	0.13	0.70	4.63	9.11
Net Debt / Equity Ratio	-0.22	-0.30	-0.23	-0.21	-0.02	0.06
Net Debt / EBITDA Ratio	-3.39	-4.27	-3.54	-3.00	-0.14	0.66
Net Debt / FCF Ratio	-6.94	-2.61	-3.56	-0.99	-0.24	0.90
Asset Turnover	0.21	0.19	0.17	0.19	0.18	0.11
Inventory Turnover	6.74	1.71	1.88	4.38	3.50	4.20
Quick Ratio	23.66	8.05	12.49	2.50	10.39	4.70
Current Ratio	24.69	8.93	14.15	2.67	11.15	5.00
Return on Equity (ROE)	5.42%	-0.53%	8.29%	-0.74%	9.98%	0.89%
Return on Assets (ROA)	1.48%	1.66%	0.79%	0.18%	3.11%	1.80%
Return on Invested Capital (ROIC)	3.36%	-6.59%	1.64%	-0.07%	8.50%	7.45%
Return on Capital Employed (ROCE)	2.00%	2.50%	1.30%	0.50%	5.30%	3.30%
Earnings Yield	1.35%	-0.20%	4.19%	-2.96%	2.21%	-0.19%
FCF Yield	0.85%	4.70%	3.70%	11.12%	2.71%	3.13%
Buyback Yield / Dilution	-6.20%	-3.00%	-5.27%	2.19%	-2.50%	14.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.